Why is "Astrocytomas" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-12 16:27:08
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Astrocytoma is a type of brain tumor. Astrocytomas originate from a specific kind of star-shaped glial cell in the cerebrum called an astrocyte. This type of tumor does not usually spread outside the brain and spinal cord, and it does not usually affect other organs. After glioblastomas, astrocytomas are the second most common glioma and can occur in most parts of the brain and occasionally in the spinal cord.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
MEK inhibition in adult patients with pilocytic astrocytomas - Nature
-
Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma - Cleveland Clinic
-
FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas - Cure Today
-
Blog: Astrocytoma vs glioblastoma – what is the difference? - Brain Tumour Research
-
Experimental therapy shows promise against deadly brain cancer - Tech Explorist
-
Clinical trial tests a newer, targeted therapy for IDH mutant astrocytoma - News-Medical
-
Recent trial reveals promising therapy for aggressive brain cancer - Medical Xpress
-
Breakthrough Trial Shows Promising Therapy for Aggressive Brain Cancer - University of Utah Health
-
Seizure Presentation of a Grade II Astrocytoma in a Patient With Ollier's Disease: A Case Report and Brief Review - Cureus
-
Unusual localization of pilocytic astrocytoma at the foramen of Monro mimicking a colloid cyst: a case report and literature review - Frontiers
-
Combination Therapy Improves Outcomes in Recurrent IDH-Mutant Astrocytoma - Neurology Today
-
Eflornithine Plus Lomustine Extends PFS, OS in Reclassified WHO Grade 3 IDH-Mutated Astrocytoma - OncLive
-
First Advance in 20 Years for Rare Brain Cancer - University of Rochester Medical Center
-
Characterization of the mutational status of glioblastoma and high-grade astrocytomas in a Latin American cohort - Nature
-
Adjuvant Temozolomide Improves Survival in 1p/19q Non-Co-Deleted Glioma - Cure Today
-
Radiotherapy for Refractory Cystic Progression in Basal Ganglia Pilocytic Astrocytoma: A Case Report - Cureus
-
A case report on IDH-mutant astrocytoma, CNS WHO grade 4: multi-omic characterization of untreated clinical progression - Frontiers
-
MB-101 Receives FDA Orphan Drug Designation for Astrocytoma and Glioblastoma - OncLive
-
Stochastic differential equation modeling approach for grading astrocytomas on brain MRI images - Nature
-
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling - Nature
-
Emerging Sub-Segments Transforming the Anaplastic Astrocytoma Market Landscape - openPR.com
-
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - Yahoo Finance
-
Astrocytoma: Causes, Symptoms, Diagnosis, Treatment, and 2025 Advances - Oncodaily
-
Case Report: Metabolic alterations and cholesterol esterification in a low-grade diffuse astrocytoma patient who progressed to glioblastoma at recurrence - Frontiers
-
Phase 3 SIGMA Trial of Safusidenib Is Initiated for IDH1-Mutant Glioma - Targeted Oncology
-
Combo treatment may offer new hope to astrocytoma patients: Trial - Rare Cancer News
-
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial - The Lancet
-
Pavlina Lenga: Challenging the Benign Paradigm of Adult Pilocytic Astrocytomas - Oncodaily
-
Behavioral Changes and Refractory Hypertension as the First Manifestations of Anaplastic Astrocytoma: A Case Report - Cureus
-
Endoscopic Resection of Pilocytic Astrocytoma of the Third Ventricle: A Case Report - European Open Science
-
Immune-hot brain tumor subtype that defies survival expectations discovered - Medical Xpress
-
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma - BioSpace
-
Early-Onset Bevacizumab-Associated Knee Osteonecrosis in a Young Adult With Astrocytoma - ACP Journals
-
New drug combination boosts life expectancy from grade 3 brain tumors by 45% or more - The Brighter Side of News
-
Leveraging transcriptomic, DNA methylation, and molecular alteration data to optimize the classification of IDH-mutant gliomas for therapy selection - Frontiers
-
Candidate gene mutations of patients with astrocytoma who present with seizures: evidence from whole exome sequencing - Frontiers
-
Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy - Neurology® Journals
-
31-Year-Old Man's Muscular Pain Was a Symptom Of Brain Cancer - SurvivorNet
-
Case 2: Low-Grade Glioma - The ASCO Post
-
Pediatric Astrocytoma: Practice Essentials, Background, Pathophysiology - Medscape
-
Anaplastic Astrocytoma Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK
-
Pseudoprogression in Pediatric Spinal Pilocytic Astrocytoma and Myxopapillary Ependymoma after Proton Therapy: A Case Series - Wiley Online Library
-
Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions - Frontiers
-
Diagnostic imaging of retinal astrocytomas: A case-series - Eye - Nature
-
Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series - Nature
-
Oral safusidenib begins trial as maintenance for high-grade glioma - Rare Cancer News
-
Brain Pathology | ISN Neuropathology Journal - Wiley Online Library
-
Extended Follow-Up Proves Vorasidenib’s Durability in IDH-Mutant Glioma - Targeted Oncology
-
ASCO-SNO Guideline Update Addresses Use of Vorasidenib for Astrocytic and Oligodendroglial Tumors - ASCO Daily News
-
Updating TCGA glioma classification through integration of molecular data following the latest WHO guidelines - Nature
-
Young adult astrocytoma survivor grateful for MD Anderson's expertise - UT MD Anderson
-
Vorasidenib approved to treat patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation - GOV.UK
-
First IDH Inhibitor for Astrocytomas and Oligodendrogliomas - American Association for Cancer Research (AACR)
-
Astrocytoma survivor: I feel lucky - UT MD Anderson
-
Astrocytoma Workup: Approach Considerations, Laboratory Studies, Imaging Studies - Medscape
-
Pilocytic Astrocytoma: Gracie's Story - Johns Hopkins Medicine
-
Diffuse Low-Grade Glioma With Spontaneous Radiological Regression: A Case to Be Followed - Cureus
-
Pleomorphic xanthoastrocytoma with multiple recurrences and continuous malignant progression to bone metastasis: a case report - Frontiers
-
Immunotherapy: A Potential Approach for High-Grade Spinal Cord Astrocytomas - Frontiers
-
Brain Pathology | ISN Neuropathology Journal - Wiley Online Library
-
Surgical approaches to intramedullary spinal cord astrocytomas in the age of genomics - Frontiers
-
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis - NEJM
-
CATNON Trial: Concurrent Versus Adjuvant Temozolomide in Treating WHO Grade 3 Astrocytomas Without 1p/19q Codeletion - CancerNetwork
-
Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells - Nature
-
Researchers report that patients with rare type of astrocytoma, a neuron tumor, have worse prognosis than expected - Medical Xpress
-
Comparative proteomic analysis of astrocytoma tissues from patients with and without seizures | Scientific Reports - Nature
-
Pilocytic Astrocytoma: What patients should better know about: 2024 updates - Oncodaily
-
Outcome of Childhood Cerebellar Pilocytic Astrocytoma: A Series With 20 Years of Follow Up - Cureus
-
Exploring targeted treatments for children with low-grade brain tumors - Boston Children's Answers
-
T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas - Neurology® Journals
-
Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes - Cureus
-
FDA OKs Trial for Novel Drug to Treat Glioblastoma and Astrocytoma - Cure Today
-
Prognostic stratification for IDH -wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA - Nature
-
Researchers report that the outcome of patients with a rare type of astrocytoma, a neuron tumor, is worse than expected - EurekAlert!
-
Amide proton transfer imaging-arterial spin labeling mismatch: a new imaging biomarker for pilocytic astrocytoma - Nature
-
Genomic profiles of IDH-mutant gliomas: MYCN- amplified IDH-mutant astrocytoma had the worst prognosis - Nature
-
Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers - Nature
-
Lenalidomide Demonstrates Promising Activity in Pediatric Gliomas/Astrocytomas - CancerNetwork
-
Eflornithine Plus Lomustine Demonstrates Clinically Meaningful Survival Benefits in Grade III IDH-Mutant Astrocytoma - OncLive
-
Subependymal Giant Cell Astrocytomas Without Tuberous Sclerosis: A Case Report on a Rare Medical Condition - Cureus
-
Combination treatment for common glioma type shows promise in mice - National Institutes of Health (.gov)
-
Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival - Nature
-
Rachel Soto, Pilocytic Astrocytoma - Stanford Medicine
-
Molecular landscape of IDH -mutant primary astrocytoma Grade IV/glioblastomas - Nature
-
Doctors Mistook Woman’s Cancer Symptoms for Arachnophobia — Now She Has Just 6 Months to Live - Times Now
-
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial - The Lancet
-
Distinct aneuploid evolution of astrocytoma and glioblastoma during recurrence | npj Precision Oncology - Nature
-
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma - Nature
-
Exploring current and future therapies for childhood astrocytoma - Open Access Government
-
Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma - Frontiers
-
Calcified Pilocytic Astrocytomas and Calcifying Pseudoneoplasms of the Neuraxis: A Diagnostic Challenge - Cureus
-
The age of adult pilocytic astrocytoma cells - Nature
-
Markey patient's rare survival helps advance brain cancer research - UKNow
-
Astrocytoma progression scoring system based on the WHO 2016 criteria - Nature
-
Astrocytoma cells interconnect to resist radiotherapy - Nature
-
Case report: Surgical treatment of an astrocytoma in the thoracic spinal cord of a cat - Frontiers
-
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas - Nature
-
Hemorrhagic Pilocytic Astrocytomas in Adults: A Case Report and Literature Review - Cureus
-
From the Archives of the AFIPRadioGraphics - RSNA Journals
-
A Rare Case of Metastases from a High-grade Astrocytoma to the Pleura, Bones, and Liver within Six Months of Diagnosis - Cureus
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.